Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
February 1st, 2019
8.8K views
SINEUPs are synthetic antisense non-coding RNAs, which contain a binding domain (BD) and an effector domain (ED) and up-regulate translation of target mRNA. Here, we describe detection methods for SINEUPs in cultured cell lines, analysis of their translation-promoting activity by Western-blot and a semi-automated high throughput imaging system.
Overview
This article discusses SINEUPs, synthetic antisense non-coding RNAs that enhance the translation of target mRNA. It outlines detection methods for SINEUPs in cultured cell lines and their translation-promoting activity through various techniques.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Molecular Biology
Background
- SINEUPs consist of a binding domain and an effector domain.
- They are designed to up-regulate translation of specific mRNAs.
- This technique can potentially address gene activity deficiencies.
- Applications include therapeutic strategies for conditions like Friedrich's ataxia.
Purpose of Study
- To explore methods for detecting SINEUPs in living cells.
- To analyze the translation-promoting effects of SINEUPs.
- To develop a high-throughput imaging system for screening target genes.
Methods Used
- Cell culture and transfection protocols for SINEUPs.
- Western blot analysis to assess protein expression levels.
- High throughput imaging for monitoring SINEUP activity.
- Use of specific reagents and conditions for protein extraction and analysis.
Main Results
- SINEUPs can induce a significant increase in protein levels.
- Successful detection of SINEUPs in cultured cells was achieved.
- High-throughput imaging provided insights into gene activity modulation.
- Methodology allows for global screening of target genes.
Conclusions
- SINEUPs represent a promising tool for gene expression modulation.
- The techniques developed can facilitate further research in gene therapy.
- Future applications may extend to various genetic deficiencies.
Frequently Asked Questions
What are SINEUPs?
SINEUPs are synthetic antisense non-coding RNAs that enhance the translation of target mRNA.
How do SINEUPs work?
They contain a binding domain and an effector domain that up-regulate translation.
What is the significance of this study?
It provides methods for detecting SINEUPs and analyzing their effects on protein expression.
What techniques are used in this research?
Western blot analysis and high-throughput imaging are key techniques used.
Can SINEUPs be used in gene therapy?
Yes, they have potential applications in addressing genetic deficiencies.
What conditions could benefit from SINEUP technology?
Conditions like Friedrich's ataxia may benefit from SINEUP-induced protein expression.
Executive Industry Relevance
SINEUPs enable targeted enhancement of protein translation without altering mRNA levels, offering a precise tool for modulating gene dosage in discovery and therapeutic contexts. This approach supports mechanistic de-risking by validating target engagement through functional protein upregulation, particularly relevant for haploinsufficiency models. The technology provides a complementary strategy to knockdown approaches, expanding the toolkit for target validation and lead identification in biopharma R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by specifically upregulating target protein expression to assess phenotypic consequences.
- Operational Value: Supports functional target validation through dose-dependent protein enhancement without transcriptional confounding.
- Predictive Value: Facilitates assessment of target sufficiency in disease models, aiding in go/no-go decisions for target progression.
Screening & Assay Development
- Scientific Value: Allows screening of SINEUP designs against target mRNAs using GFP-tagged reporters to identify optimal binding domains.
- Operational Value: Employs semi-automated high-throughput imaging to quantify translation enhancement, improving scalability over traditional Western blot.
- Assay Readiness: Generates quantitative fluorescence readouts that correlate with protein upregulation, enabling reproducible compound or effector screening.
Translational & Preclinical Research
- Scientific Value: Demonstrated efficacy in human, mouse, and insect cell lines, supporting cross-species target validation.
- Translational Continuity: Enables progression from in vitro screening to in vivo models, as shown in preclinical systems for haploinsufficiency.
- De-risking: Reduces mechanistic ambiguity by confirming that phenotypic effects stem from enhanced translation rather than off-target transcriptional changes.
Pipeline & Workflow Integration
SINEUPs function as a discovery-stage tool for target validation, bridging hypothesis testing and lead identification by providing functional readouts of target sufficiency.
- Discovery Biology: Supports target validation by enabling specific upregulation of endogenous or exogenous proteins to assess pathway engagement.
- Screening: Enables assay development via GFP-tagged mRNA reporters and high-throughput imaging to evaluate SINEUP potency and specificity.
- Analytics: Generates quantitative protein and fluorescence data that allow comparison of SINEUP designs and dose-dependent effects.
- Translational Research: Supports preclinical continuity by demonstrating activity in vivo, particularly for protein replacement strategies.
- Enterprise Reuse: Represents a modular platform adaptable to multiple targets, supporting reuse across projects and therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by enabling precise, post-transcriptional control of protein levels.
- Operational Value: Offers a reusable, semi-automated imaging workflow that increases throughput and reduces reliance on endpoint assays.
- Strategic Value: Improves target selection by providing functional evidence of sufficiency, reducing late-stage failure risk.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on demonstrable protein upregulation phenotypes.
Implementation Considerations
- Requires expertise in nucleic acid design, particularly for optimizing binding domain complementarity to the 5' UTR and start codon.
- Depends on access to transfection instrumentation and fluorescence imaging systems for high-throughput screening.
- Necessitates standardization of SINEUP design and transfection protocols across cell lines to ensure reproducibility.
- Requires validation that observed phenotypes are due to translation enhancement and not mRNA stability changes.
- Limited by the need to empirically test binding domain size and position for optimal activity per target.
Biopharma FAQs
Why is null hypothesis testing important for SINEUP target validation?
Null hypothesis testing helps determine whether observed protein upregulation is statistically significant compared to controls, ensuring that SINEUPs specifically enhance translation without altering mRNA levels. This supports rigorous target validation by distinguishing specific effects from experimental variability.
How does isolating the independent variable (SINEUP design) fit into the discovery pipeline?
By varying binding domain length and position relative to the start codon, researchers can isolate the impact of SINEUP design on translation efficiency. This enables systematic optimization of effector molecules for target-specific activity in early discovery.
What do quantitative dependent variable measurements (e.g., GFP intensity) enable in SINEUP studies?
Quantitative fluorescence measurements allow precise assessment of translation enhancement, enabling comparison of SINEUP potency and dose-response relationships. These data support go/no-go decisions based on measurable protein upregulation thresholds.
Why are replication requirements critical for cross-functional collaboration in SINEUP workflows?
Replication across wells and experiments ensures that fluorescence and Western blot signals are consistent and reliable, which is essential for sharing data between discovery, assay development, and translational teams. Standardized replication builds confidence in SINEUP efficacy across sites.
What statistical analysis capabilities are needed before implementing SINEUPs in a screening campaign?
Teams require the ability to calculate fold-change, standard deviation, and significance (e.g., t-tests or ANOVA) from replicate fluorescence or Western blot data to evaluate SINEUP activity. This enables objective comparison of designs and identification of hits with robust translation enhancement.
Chapters in this video
0:04
Title
0:48
Design of Binding Domains (BDs) of SINEUP Constructs for Target mRNAs
1:48
Cell Culture and SINEUPs Transfection
3:46
Protein Extraction
5:32
Protein Separation by SDS-PAGE and Detection of Target Proteins by Western-blot Analysis
7:21
Imaging Analysis of SINEUPs by Semi-automated Detection Method
8:26
Results: Analysis of Translation Upregulation by SINEUP-GFP
9:11
Conclusion
